Hemodynamic effects of intravenous paracetamol in critically ill children with septic shock on inotropic support

Elhanan Nahum1,2, Avichai Weissbach1,2, Eytan Kaplan1,2

  • 11Pediatric Intensive Care Unit, Schneider Children's Medical Center of Israel, 14 Kaplan St., 4920235 Petach Tikva, Israel.

Journal of Intensive Care
|February 5, 2020
PubMed

Insights

Intravenous paracetamol can cause hypotension in critically ill children receiving inotropic support. Healthcare providers should monitor for and be prepared to intervene in these hypotensive events.

Area of Science:

  • Pediatric critical care medicine
  • Pharmacology
  • Cardiovascular physiology

Background:

  • Intravenous paracetamol use in critically ill adults is associated with hemodynamic impairment.
  • Limited data exist on the effects of intravenous paracetamol on hemodynamics in pediatric patients.

Purpose of the Study:

  • To investigate the incidence, severity, and risk factors of hypotension after intravenous paracetamol administration in children with septic shock requiring inotropic support.

Main Methods:

  • Retrospective review of electronic medical charts for children (1 month to 18 years) with septic shock on inotropic support.
  • Collected data included demographics, diagnoses, Pediatric Logistic Organ Dysfunction (PELOD) scores, and hemodynamic parameters pre- and post-paracetamol.
  • Assessed changes in blood pressure, hypotension, and need for intervention (inotropic support or fluid bolus).

Main Results:

  • 45 children were included; 105 doses of intravenous paracetamol were administered.
  • A significant decrease in systolic blood pressure was observed at 30, 60, 90, and 120 minutes post-administration.
  • Mean arterial pressure decreased by ≥15% in 7.6% to 17.1% of doses, with 11.4% of administrations requiring intervention.

Conclusions:

  • Hypotensive events are relatively common in critically ill children receiving intravenous paracetamol while on inotropic support.
  • Clinicians must remain vigilant for these events and be prepared for necessary interventions.
Abstract

Related Concept Videos

Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.1K
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
515
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
205
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
147
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
774
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
465